[1]
Kalal, C., Joshi, H., Zanwar, S. and Premkumar, M. 2025. Tolvaptan Improves Refractory Ascites and Overall Survival in Cirrhosis: A Meta-Analysis. Current Internal Medicine Research and Practice Surabaya Journal. 6, 1 (Jan. 2025), 65–73.